Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Talen Energy Corp V.TLN


Primary Symbol: TLN

Talen Energy Corporation is an independent power producer and infrastructure company. The Company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States. The Company produces and sells electricity, capacity, and ancillary services into wholesale United States power markets, including PJM and WECC, with its generation fleet principally located in the Mid-Atlantic and Montana. While the majority of its power is already generated at zero-carbon nuclear and lower-carbon gas-fired facilities, it is reducing the carbon profile of its wholly owned coal fleet through conversion to lower-carbon fuels. Its plants generate power using a variety of fuels, ranging from zero-carbon energy like nuclear to gas, coal and oil, with some possessing dual fuel switching capabilities. In addition, the Company is developing a hyperscale data center campus adjacent to its Susquehanna nuclear plant that utilizes the carbon-free energy that Susquehanna generates.


NDAQ:TLN - Post by User

Bullboard Posts
Post by Everswanon May 15, 2009 12:10pm
271 Views
Post# 15996188

Nexamar miss/ hit trials lung cancer

Nexamar miss/ hit trials lung cancer

https://www.reuters.com/article/rbssHealthcareNews/idUSLF3018820090515

Everyone is getting into lung cancer. Competition is heating between the giants pharmas.

All their drugs sucks, not much improvement than with chemeo...

Expensive. Side effects...

They all need TLN-4601 to increase efficacy and win the cancer war...

Another hit miss trial for Nexamar...

Bullboard Posts